Pathogenesis and management of antiphospholipid syndrome.

about

Peripheral B-Cell Subset Distribution in Primary Antiphospholipid Syndrome.Cellular and Molecular Mechanisms of Anti-Phospholipid Syndrome.Coronary Artery Thromboses, Stent Thrombosis and Antiphospholipid Antibody Syndrome: Case Report.

P2860

Q49805093-9E5EFA52-797A-4CB7-BE3A-0239A4C37C33 Q54996884-975B631E-5B95-4DF7-BB86-D523C5F1D5E5 Q55035223-986C2F96-2119-4F6D-AFCE-4E5490C0F808

P2860

Pathogenesis and management of antiphospholipid syndrome.

Item

http://www.wikidata.org/entity/Q39198671

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Pathogenesis and management of antiphospholipid syndrome.

@en

Pathogenesis and management of antiphospholipid syndrome.

@nl

type

Item

label

Pathogenesis and management of antiphospholipid syndrome.

@en

Pathogenesis and management of antiphospholipid syndrome.

@nl

prefLabel

Pathogenesis and management of antiphospholipid syndrome.

@en

Pathogenesis and management of antiphospholipid syndrome.

@nl

P1476

Pathogenesis and management of antiphospholipid syndrome.

@en

P2093

Deepa R J Arachchillage

http://www.w3.org/2001/XMLSchema#string

Mike Laffan

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

AKT/PKB signaling: navigating downstream

Examining the prevalence of non-criteria anti-phospholipid antibodies in patients with anti-phospholipid syndrome: a systematic review

Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke

A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)

Antiphospholid antibodies regulate the expression of trophoblast cell adhesion molecules

Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals

Brief report: induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

P304

181-195

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.14632

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

178

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28339096

http://www.w3.org/2001/XMLSchema#string

Pathogenesis and management of antiphospholipid syndrome.

about

P2860

P2860

Pathogenesis and management of antiphospholipid syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698